| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,233 |
1,880 |
$165K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,497 |
2,837 |
$162K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,809 |
1,594 |
$92K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
628 |
567 |
$48K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
487 |
354 |
$37K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
387 |
359 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,518 |
456 |
$24K |
| 87428 |
|
347 |
305 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
799 |
674 |
$20K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
604 |
583 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,035 |
868 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
909 |
738 |
$15K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
188 |
163 |
$13K |
| 96127 |
|
638 |
573 |
$9K |
| 99173 |
|
1,146 |
1,035 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
593 |
518 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
73 |
65 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
96 |
90 |
$3K |
| 0071A |
|
58 |
31 |
$2K |
| 0072A |
|
49 |
25 |
$2K |
| 99000 |
|
89 |
69 |
$2K |
| D1206 |
Topical application of fluoride varnish |
31 |
15 |
$728.00 |
| 0001A |
|
13 |
13 |
$545.68 |
| 83655 |
|
20 |
12 |
$237.20 |
| 85018 |
|
24 |
16 |
$55.68 |